Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

AZD-2373 begins first-in-human trial in healthy male subjects of African ancestry

March 11, 2020

FDA approves Procysbi delayed-release oral granules in packets

Feb. 19, 2020

Allena plans protocol amendment for second pivotal trial of reloxaliase for enteric hyperoxaluria

Feb. 12, 2020

New hydroxyacid oxidase 1 inhibitors discovered at Orfan Biotech

Jan. 28, 2020

LNA-anti-miR-150 ameliorates FSGS in vivo

Jan. 28, 2020

Sanifit opens enrollment in phase III study of SNF-472 for calciphylaxis

Jan. 14, 2020

Scripps Research Institute presents myosin-2 ATPase activity inhibitors

Jan. 8, 2020

Phase II study begins for URO-902 in overactive bladder

Dec. 24, 2019

Phase I study of Metablok achieves primary endpoints

Dec. 19, 2019

DiaMedica initiates phase II study of DM-199 in chronic kidney disease

Dec. 18, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...